Literature DB >> 29209986

Data on Single Nucleotide Polymorphism of DNA Repair Genes and Breast Cancer Risk from Poland.

Beata Smolarz1, Magdalena Bryś2, Ewa Forma2, Marek Zadrożny3, Jan Bieńkiewicz4, Hanna Romanowicz5.   

Abstract

Single nucleotide polymorphisms (SNPs) may modify the risk of cancer. They may be then regarded as potential markers of carcinogenesis. The aim of this study was to analyze the frequency of genotypes and alleles of SNPs in DNA repair genes and to investigate the influence this genetic variation exerts on breast cancer in Polish females. The test group comprised 600 females with breast cancer and 600 healthy controls. Genomic DNA was isolated and the SNPs in DNA repair genes were determined by High-Resolution Melter (HRM) technique. Following polymorphisms were analysed: Arg399Gln (rs25487) of the XRCC1, Gly322Asp (rs4987188) of the hMSH2, Lys751Gln (rs13181) of the XPD, Arg188His (rs3218536) of the XRCC2, P871L (rs799917) of the BRCA1 and N372H (rs144848) of the BRCA2 gene. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for each genotype and allele. Statistically significant correlations were identified between 4 single nucleotide polymorphisms and the breast cancer risk: rs25487 rs4987188 rs13181 and rs799917. The alleles XRCC1-Gln (OR 5.11; 95% CI 5.68-11.64, p < .0001), hMSH2-Asp (OR 4.66; 95% CI 3.90-5.56, p < .0001), XPD-Gln (OR 2.65; 95% CI 2.24-3.14, p < .0001) and BRCA1-L (OR 1.45; 95% CI 1.24-1.71, p < .0001) genes were strongly correlated with this malignancy. No correlation was found between the studied SNPs and tumor grading nor the lymph node status. Further research on larger groups is warranted to determine the influence of above-mentioned genetic variants on breast cancer risk.

Entities:  

Keywords:  Breast cancer; DNA repair; Single nucleotide polymorphism

Mesh:

Substances:

Year:  2017        PMID: 29209986     DOI: 10.1007/s12253-017-0370-8

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  31 in total

1.  EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century.

Authors:  M P Coleman; G Gatta; A Verdecchia; J Estève; M Sant; H Storm; C Allemani; L Ciccolallo; M Santaquilani; F Berrino
Journal:  Ann Oncol       Date:  2003       Impact factor: 32.976

2.  Associated risk of XRCC1 and XPD cross talk and life style factors in progression of head and neck cancer in north Indian population.

Authors:  Anil Kumar; Mohan Chand Pant; Hirdya Shanker Singh; Shashi Khandelwal
Journal:  Mutat Res       Date:  2011-09-16       Impact factor: 2.433

Review 3.  DNA double-strand breaks: signaling, repair and the cancer connection.

Authors:  K K Khanna; S P Jackson
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

Review 4.  Subtyping of triple-negative breast cancer: implications for therapy.

Authors:  Vandana G Abramson; Brian D Lehmann; Tarah J Ballinger; Jennifer A Pietenpol
Journal:  Cancer       Date:  2014-07-16       Impact factor: 6.860

5.  Survival patterns in lung and pleural cancer in Europe 1999-2007: Results from the EUROCARE-5 study.

Authors:  Silvia Francisci; Pamela Minicozzi; Daniela Pierannunzio; Eva Ardanaz; Andrea Eberle; Tom K Grimsrud; Arnold Knijn; Ugo Pastorino; Diego Salmerón; Annalisa Trama; Milena Sant
Journal:  Eur J Cancer       Date:  2015-09-26       Impact factor: 9.162

6.  Polymorphisms in DNA repair genes, recreational physical activity and breast cancer risk.

Authors:  Lauren E McCullough; Regina M Santella; Rebecca J Cleveland; Robert C Millikan; Andrew F Olshan; Kari E North; Patrick T Bradshaw; Sybil M Eng; Mary Beth Terry; Jing Shen; Katherine D Crew; Pavel Rossner; Susan L Teitelbaum; Alfred I Neugut; Marilie D Gammon
Journal:  Int J Cancer       Date:  2013-08-29       Impact factor: 7.396

Review 7.  The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway.

Authors:  Michael R Lieber
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

8.  Cancer risks for MLH1 and MSH2 mutation carriers.

Authors:  James G Dowty; Aung K Win; Daniel D Buchanan; Noralane M Lindor; Finlay A Macrae; Mark Clendenning; Yoland C Antill; Stephen N Thibodeau; Graham Casey; Steve Gallinger; Loic Le Marchand; Polly A Newcomb; Robert W Haile; Graeme P Young; Paul A James; Graham G Giles; Shanaka R Gunawardena; Barbara A Leggett; Michael Gattas; Alex Boussioutas; Dennis J Ahnen; John A Baron; Susan Parry; Jack Goldblatt; Joanne P Young; John L Hopper; Mark A Jenkins
Journal:  Hum Mutat       Date:  2013-03       Impact factor: 4.878

9.  Extracolonic manifestations of lynch syndrome.

Authors:  Brian J Bansidhar
Journal:  Clin Colon Rectal Surg       Date:  2012-06

10.  Relationship between Rad51 G135C and G172T variants and the susceptibility to cancer: a meta-analysis involving 54 case-control studies.

Authors:  Mengmeng Zhao; Pin Chen; Yanbin Dong; Xianji Zhu; Xilong Zhang
Journal:  PLoS One       Date:  2014-01-27       Impact factor: 3.240

View more
  2 in total

1.  A meta-analysis of XRCC1 single nucleotide polymorphism and susceptibility to gynecological malignancies.

Authors:  Xue Qin Zhang; Li Li
Journal:  Medicine (Baltimore)       Date:  2021-12-17       Impact factor: 1.817

Review 2.  Do non-pathogenic variants of DNA mismatch repair genes modify neurofibroma load in neurofibromatosis type 1?

Authors:  Anja Harder
Journal:  Childs Nerv Syst       Date:  2022-01-08       Impact factor: 1.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.